Navigation Links
Neuralstem Completes Phase Ia in Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial
Date:10/27/2011

, which the company plans to develop into orally administered drugs for major depression and other psychiatric disorders.

NSI-189 stimulated neurogenesis of human hippocampus-derived neural stem cells in- vitro. In mice, NSI-189 stimulated neurogenesis in the hippocampus and increased its volume. In humans, NSI-189 may reverse the human hippocampal atrophy seen in major depression and other disorders. This program has received significant support from both the Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH).

About Neuralstem

Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem is conducting an ongoing FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's disease, and has been awarded orphan status designation by the FDA.

In addition to ALS, the company is also targeting major central nervous system conditions with its cell therapy platform, including spinal cord injury, ischemic spastic paraplegia, chronic stroke, and Huntington's disease. The company has submitted an IND (Investigational New Drug) application to the FDA for a Phase I safety trial in chronic spinal cord injury.

Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain's capacity to generate new neurons, possibly reversing the pathologies of some central nervous system conditions.  Neuralstem's first small molecule compound, NSI-189 is currently in a Phase I FDA-approved safety trial in major depr
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neuralstem Announces Issuance of Core Technology Patent in Europe
2. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
3. Neuralstems ALS Trial on Clinical Hold
4. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
5. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
6. Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
7. Neuralstem Updates ALS Clinical Trial Progress
8. Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial
9. Neuralstem Updates NSI-189 Major Depression Trial
10. Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents
11. Dr. Eva Feldman, Principal Investigator, Presents Interim Data on Neuralstem ALS Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Research and Markets( http://www.researchandmarkets.com/research/hmdflj/outlook_of_global ... of Global Biologic Drug Discovery Outsourcing Market" report ... discovery outsourcing market will likely grow in a CAGR ... $11.4 B by 2020. It has been ... become a new but important type of medication. They ...
(Date:7/7/2015)... -- Dedicated to promoting wellness and giving back to its ... purple pledge in support of Alzheimer,s & Brain-Awareness Month. ... time to shine a purple light for the millions ... in our community who are affected by Alzheimer,s. Raising ... helps mobilize friends, family members, neighbors and coworkers to ...
(Date:7/7/2015)... , July 7, 2015 The ... USD 1,197.7 million by 2020, growing at an estimated CAGR ... study by Grand View Research, Inc. Introduction of innovative technologies ... with growing awareness levels pertaining to the advantages of breast ... next six years. In addition, presence of untapped growth opportunities ...
Breaking Medicine Technology:Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 3Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4
(Date:7/7/2015)... ... ... Owners of Green Ladies Cleaning are very pleased to announce that they are ... only be gained by votes from Madison Magazine readership. , The company says that ... use daily. Having a home cleaned with all-natural products means that residents of apartments, ...
(Date:7/7/2015)... ... July 07, 2015 , ... This week ... their brand new website. The website’s goal is to provide patients with detailed ... patient tools, including requesting appointments online. , Part of the center’s rebranding efforts, ...
(Date:7/7/2015)... ... 07, 2015 , ... Celestix Networks, the leading provider of ... Series virtual appliances. These virtual platforms expand the existing physical appliances under ... to simplify the on-premises deployment of unified remote access and single sign-on (SSO). ...
(Date:7/7/2015)... , ... July 07, 2015 , ... At the end of June Pacific Prime Renewals ... ‘go green’ . This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not ... , On this initiative Cotton explained, “We send anything between 300 and 600 pieces ...
(Date:7/7/2015)... ... July 07, 2015 , ... On Saturday, May 16th, ... at the Manistee Golf and Country Club. Best Drug Rehabilitation staff members were delighted ... cause, helping underprivileged children. Kiwanis International, the parent of the Manistee Kiwanis Club, is ...
Breaking Medicine News(10 mins):Health News:Environmentally-Friendly House Cleaning Company Wins Best of Madison Magazine Award 2Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2
... rise of the central nervous system [CNS] in animal ... worms evolved// from the same ancestor, but their CNSs ... after their lineages had split during evolution. Researchers from ... reveal that the vertebrate nervous system is probably much ...
... need to pull up its socks on health issues, lest ... leader of chronic diseases’. If the present trend continues//, 66% ... ,A study conducted by Assocham and Price ... has shown the vulnerability of the Indian population to cardiovascular ...
... focused on motivating seniors and others with Medicare to make ... the U.S. Department of Health and Human Services (HHS) and ... is titled: A Healthier US Starts Here. , ... and summer, the Medicare Prevention tour bus will visit each ...
... U.S. Food and Drug Administration (FDA) is alerting health ... broadcasts that provide emerging// drug safety information. The broadcasts, ... computers and personal audio players. ,The service ... and speed its communications concerning the safety of ...
... modern lifestyle, which puts people under constant stress, could ... kidney disease// and dementia, scientists have warned. ... eating a poor diet, drinking too much alcohol and ... of developing heart problems. ,For some people, ...
... A peptide found in human blood inhibited 60 strains ... to a study published Thursday in the journal Cell//, ... can inhibit HIV strains that have developed resistance to ... development of new HIV/AIDS drugs -- the Chronicle reports. ...
Cached Medicine News:Health News:The Origin of the Brain Lies in a Worm 2Health News:Seniors Encouraged To Make Use Of Medicare’s Freebie 2Health News:FDA Announces Audio Broadcasts on Emerging Drug Safety Information 2Health News:Modern Lifestyle Could Damage Heart 2Health News:Peptide Found in Human Blood Inhibits 60 Strains of HIV, Study Says 2
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... The Trinity Biotech Captia™ ... Assay (ELISA) is intended for ... antibodies (IgG and IgM) to ... in serum from patients with ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: